Given their consent, it should be made possible for patients suffering from cancer to call specialists from other sites within so-called molecular tumour conferences.

In addition to treatment and disease progression data, genomic data must also be processed and presented to the physicians participating in such tumour conferences. With the help of these data, similar patients can be identified in order to predict the further course of the disease and enable an individualized treatment.